amphetamine has been researched along with Anxiety in 138 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study assessed behaviour, as measured by 50kHz calls related to positive affect, in rats with different fear conditioned response strengths: low-anxiety rats (LR) and high-anxiety rats (HR), after amphetamine injection in a two-injection protocol (TIPS)." | 7.80 | High-anxiety rats are less sensitive to the rewarding affects of amphetamine on 50kHz USV. ( Kaniuga, E; Lehner, MH; Płaźnik, A; Skórzewska, A; Sobolewska, A; Taracha, E; Turzyńska, D; Wisłowska-Stanek, A; Wróbel, J, 2014) |
| "Withdrawal from amphetamine is associated with increased anxiety and sensitivity to stressors which are thought to contribute to relapse." | 7.80 | Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal. ( Cook, A; Forster, GL; Mears, M; Renner, KJ; Scholl, JL; Tu, W; Watt, MJ, 2014) |
| "Chronic amphetamine use results in anxiety-like states after drug cessation." | 7.79 | The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats. ( Gibula-Bruzda, E; Koltunowska, D; Kotlinska, JH, 2013) |
| "Withdrawal from psychostimulants increases anxiety states, and amphetamine-treated rats show increased CRF(2) receptors in the serotonergic cell body region, the dorsal raphe nucleus (dRN)." | 7.76 | Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism. ( Forster, GL; Oliver, HA; Oliver, KM; Scholl, JL; Vuong, SM, 2010) |
| "Acute amphetamine administration activates monoaminergic pathways and increases systemic corticosterone, both of which influence anxiety states and adult dentate gyrus neurogenesis." | 7.76 | Withdrawal from chronic amphetamine produces persistent anxiety-like behavior but temporally-limited reductions in monoamines and neurogenesis in the adult rat dentate gyrus. ( Barr, JL; Forster, GL; Renner, KJ, 2010) |
| "Although we could not establish an association between the anxiety level of rats with either the onset or severity of LID, our results showed that citalopram was able to mediate a partial alleviation in LID after chronic treatment, and the extent of recovery was negatively correlated to the anxiety measures of individual animals." | 7.74 | The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram. ( Barker, RA; Kuan, WL; Zhao, JW, 2008) |
| "Seventy unwed pregnant patients in states of mild to moderate depression evidenced by one or more symptoms (tenseness, "nervousness," crying spells, listlessness, fatigue, nausea and vomiting, insomnia and overeating), received informal psychotherapy and a sustained-release capsule combining d-amphetamine sulfate and amobarbital." | 7.63 | Prepartum depression; a study of seventy unwed mothers treated with d-amphetamine sulfate and amobarbital. ( CALDWELL, WG; NOWERS, W, 1958) |
| "Amphetamine is thought to produce its stimulant effects mainly via the dopamine system, but its effects may also be influenced by other systems." | 6.71 | Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. ( Baune, BT; Cook, EH; de Wit, H; Deckert, J; Hohoff, C; McDonald, JM, 2005) |
| " Mice treated with PGW5 (25 and 50mg/kg/d) for 28 days did not show toxic effects in terms of weight gain and blood-chemistry analysis." | 5.40 | A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia. ( Bidder, M; Gil-Ad, I; Kramer, M; Portnoy, M; Taler, M; Tarasenko, I; Weizman, A, 2014) |
| "Schizophrenia is believed to arise from an interaction of genetic predisposition and adverse environmental factors, with stress being a primary variable." | 5.39 | Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia. ( Du, Y; Grace, AA, 2013) |
| " In rats, withdrawal from chronic amphetamine increases OCT3 expression in specific limbic brain regions involved anxiety and stress responses, including the ventral hippocampus, central nucleus of amygdala (CeA) and dorsomedial hypothalamus." | 4.31 | Chronic administration of glucocorticoid receptor ligands increases anxiety-like behavior and selectively increase serotonin transporters in the ventral hippocampus. ( Forster, GL; Renner, KJ; Scholl, JL; Solanki, RR; Watt, MJ, 2023) |
| "Kava extract (Piper methysticum) is a phytotherapic mainly used for the treatment of anxiety." | 4.02 | Kava decreases the stereotyped behavior induced by amphetamine in mice. ( Barbosa, CP; Boligon, AA; Chiapinotto Ceretta, AP; da Silva Córneo, E; de Moraes Reis, E; Fachinetto, R; Krum, BN; Machado-de-Ávila, RA; Molz de Freitas, C; Scussel, R, 2021) |
| " The primary objective of the current study was to assess differences in blood pressure and heart rate before and after induction of anesthesia between patients on chronic amphetamine or methylphenidate therapy who receive their normal dose preoperatively compared to patients in whom the prescribed medication was withheld." | 3.85 | Hemodynamic profile and behavioral characteristics during induction of anesthesia in pediatric patients with attention deficit hyperactivity disorder. ( Cartabuke, RS; Rice, J; Tobias, JD; Tumin, D, 2017) |
| "This study assessed behaviour, as measured by 50kHz calls related to positive affect, in rats with different fear conditioned response strengths: low-anxiety rats (LR) and high-anxiety rats (HR), after amphetamine injection in a two-injection protocol (TIPS)." | 3.80 | High-anxiety rats are less sensitive to the rewarding affects of amphetamine on 50kHz USV. ( Kaniuga, E; Lehner, MH; Płaźnik, A; Skórzewska, A; Sobolewska, A; Taracha, E; Turzyńska, D; Wisłowska-Stanek, A; Wróbel, J, 2014) |
| "Withdrawal from amphetamine is associated with increased anxiety and sensitivity to stressors which are thought to contribute to relapse." | 3.80 | Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal. ( Cook, A; Forster, GL; Mears, M; Renner, KJ; Scholl, JL; Tu, W; Watt, MJ, 2014) |
| "Chronic amphetamine use results in anxiety-like states after drug cessation." | 3.79 | The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats. ( Gibula-Bruzda, E; Koltunowska, D; Kotlinska, JH, 2013) |
| " GFAP-DNSynCAM1 mice also display high levels of basal activity in the dark period (the rodent's awake/active time) that are attenuated by the psychostimulant D,L-amphetamine, and reduced anxiety levels in response to both avoidable and unavoidable provoking stimuli." | 3.78 | Astrocyte-specific disruption of SynCAM1 signaling results in ADHD-like behavioral manifestations. ( Alderman, Z; Corfas, G; Ojeda, SR; Raber, J; Sandau, US, 2012) |
| "Acute amphetamine administration activates monoaminergic pathways and increases systemic corticosterone, both of which influence anxiety states and adult dentate gyrus neurogenesis." | 3.76 | Withdrawal from chronic amphetamine produces persistent anxiety-like behavior but temporally-limited reductions in monoamines and neurogenesis in the adult rat dentate gyrus. ( Barr, JL; Forster, GL; Renner, KJ, 2010) |
| "Withdrawal from psychostimulants increases anxiety states, and amphetamine-treated rats show increased CRF(2) receptors in the serotonergic cell body region, the dorsal raphe nucleus (dRN)." | 3.76 | Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism. ( Forster, GL; Oliver, HA; Oliver, KM; Scholl, JL; Vuong, SM, 2010) |
| "Although we could not establish an association between the anxiety level of rats with either the onset or severity of LID, our results showed that citalopram was able to mediate a partial alleviation in LID after chronic treatment, and the extent of recovery was negatively correlated to the anxiety measures of individual animals." | 3.74 | The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram. ( Barker, RA; Kuan, WL; Zhao, JW, 2008) |
| "The effects of the anxiogenic agents FG7142, caffeine, pentylenetetrazole, and amphetamine were assessed in two anxiety situations in the marmoset, first in an "anxiogenic" test based on the animal's response to a human observer standing in front of the home cage and second in a low-anxiety situation where animals behaviour was videotaped in the absence of the observer." | 3.68 | Behavioural effects of anxiogenic agents in the common marmoset. ( Carey, GJ; Costall, B; Domeney, AM; Jones, DN; Naylor, RJ, 1992) |
| "Seventy unwed pregnant patients in states of mild to moderate depression evidenced by one or more symptoms (tenseness, "nervousness," crying spells, listlessness, fatigue, nausea and vomiting, insomnia and overeating), received informal psychotherapy and a sustained-release capsule combining d-amphetamine sulfate and amobarbital." | 3.63 | Prepartum depression; a study of seventy unwed mothers treated with d-amphetamine sulfate and amobarbital. ( CALDWELL, WG; NOWERS, W, 1958) |
| " However, their chronic use is related to memory loss, emotional instability, insomnia, psychosis and paranoia." | 1.46 | Influence of physical activity on addiction parameters of rats exposed to amphetamine which were previously supplemented with hydrogenated vegetable fat. ( Antoniazzi, CTD; Barcelos, RCS; Burger, ME; Emanuelli, T; Kronbauer, M; Metz, VG; Piccolo, JC; Rosa, HZ; Roversi, K; Segat, HJ; Veit, JC; Vey, LT, 2017) |
| "Amphetamine (AMPH) is an addictive psychostimulant drug whose use has been related to neurotoxicity." | 1.42 | Cross-Generational trans Fat Consumption Favors Self-Administration of Amphetamine and Changes Molecular Expressions of BDNF, DAT, and D1/D2 Receptors in the Cortex and Hippocampus of Rats. ( Bürger, ME; de Freitas, DL; Dias, VT; Emanuelli, T; Kuhn, FT; Pase, CS; Roversi, K; Veit, JC; Vey, LT, 2015) |
| "Other PTSD symptoms, such as anxiety (elevated plus maze) and hyperarousal (acoustic startle response), were also investigated in these rats." | 1.40 | Only susceptible rats exposed to a model of PTSD exhibit reactivity to trauma-related cues and other symptoms: an effect abolished by a single amphetamine injection. ( Gisquet-Verrier, P; Toledano, D, 2014) |
| " Mice treated with PGW5 (25 and 50mg/kg/d) for 28 days did not show toxic effects in terms of weight gain and blood-chemistry analysis." | 1.40 | A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia. ( Bidder, M; Gil-Ad, I; Kramer, M; Portnoy, M; Taler, M; Tarasenko, I; Weizman, A, 2014) |
| "Schizophrenia is believed to arise from an interaction of genetic predisposition and adverse environmental factors, with stress being a primary variable." | 1.39 | Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia. ( Du, Y; Grace, AA, 2013) |
| "It also decreased catalepsy and weight gain induced by APDs, suggesting that it may decrease APD-induced extrapyramidal side effects (EPS) and compliance." | 1.37 | AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents. ( Arad, M; Barak, S; Black, MD; Borowsky, B; Cohen, C; De Levie, A; Featherstone, RE; Giardino, O; Griebel, G; Pichat, P; Rogacki, N; Senyah, Y; Stemmelin, J; Stevens, RJ; Varty, GB; Weiner, I, 2011) |
| " Amphetamine and diazepam produced an inverted U-shaped dose-response effect on different parameters of the test and demonstrate that the drug concentration which elicited a peak in mean number of entries is different from the drug concentration which elicited a peak in mean duration of entries." | 1.36 | Distinguishing anxiolysis and hyperactivity in an open space behavioral test. ( Chazot, PL; Ennaceur, A; Michalikova, S; van Rensburg, R, 2010) |
| "Using the rat Maximal Electroshock Seizure Threshold (MEST) test, (S)-3,4-DCPG (30 mg/kg, i." | 1.34 | Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia. ( Harris, AJ; Honey, A; Jones, DN; Jones, GA; Kelly, FM; Kew, JN; Maycox, PR; Melarange, RA; Murdock, PR; Robbins, MJ; Rocheville, M; Rourke, C; Rupniak, T; Soffin, EM; Starr, KR; Strum, J, 2007) |
| "Several psychiatric disorders are associated with white matter defects, suggesting that oligodendrocyte (OL) abnormalities underlie some aspects of these diseases." | 1.34 | Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. ( Benoit-Marand, M; Brunner, D; Chen, C; Corfas, G; Edgar, N; El-Khodor, BF; Hooks, BM; Moore, H; Murtie, JC; O'Donnell, P; Roy, K; Sardi, SP, 2007) |
| "Diazepam pre-treatment did not restore the expression of amphetamine CPP." | 1.31 | Diazepam modifies the effect of pedunculopontine lesions on morphine but not on amphetamine conditioned place preference. ( Franklin, KB; Leri, F, 2000) |
| "When FG 7142 (20 mg/kg) was administered during five consecutive days before behavioral testing, its anxiogenic-like effect first deepened, but waned off by the fifth session." | 1.30 | Characterization of rat exploratory behavior using the exploration box test. ( Allikmets, L; Harro, J; Matto, V; Otter, MH; Skrebuhhova, T; Sõukand, R, 1997) |
| " Chronic administration of chlordiazepoxide in the diet of the maternal rat also produced an increased exploratory activity in the weanlings." | 1.27 | Differential effects of benzodiazepines and amphetamine on exploratory behaviour in weanling rats: an animal model for anxiolytic activity. ( Salt, JS; Taberner, PV, 1984) |
| " Chronic administration dissociated the pattern of results produced by sodium phenobarbitone (35 mg/kg) from that produced by flurazepam (0." | 1.26 | A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants. ( File, SE; Hyde, JR, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 50 (36.23) | 18.7374 |
| 1990's | 10 (7.25) | 18.2507 |
| 2000's | 22 (15.94) | 29.6817 |
| 2010's | 52 (37.68) | 24.3611 |
| 2020's | 4 (2.90) | 2.80 |
| Authors | Studies |
|---|---|
| Scholl, JL | 6 |
| Solanki, RR | 3 |
| Watt, MJ | 5 |
| Renner, KJ | 5 |
| Forster, GL | 7 |
| Arab, AO | 1 |
| Alasmari, F | 1 |
| Albaker, AB | 1 |
| Alhazmi, HA | 1 |
| Alameen, AA | 1 |
| Alagail, NM | 1 |
| Alwaeli, SA | 1 |
| Rizwan Ahamad, S | 1 |
| AlAsmari, AF | 1 |
| AlSharari, SD | 1 |
| Niedzielak, T | 1 |
| Ravenelle, R | 1 |
| Joseph, M | 1 |
| Calhoun, C | 1 |
| Plotkin, B | 1 |
| Jones, R | 1 |
| Herrera, M | 1 |
| Tiffany Donaldson, S | 1 |
| Krum, BN | 1 |
| Molz de Freitas, C | 1 |
| Chiapinotto Ceretta, AP | 1 |
| Barbosa, CP | 1 |
| de Moraes Reis, E | 1 |
| Scussel, R | 1 |
| da Silva Córneo, E | 1 |
| Machado-de-Ávila, RA | 1 |
| Boligon, AA | 1 |
| Fachinetto, R | 1 |
| Lehner, M | 2 |
| Gryz, M | 3 |
| Wisłowska-Stanek, A | 4 |
| Turzyńska, D | 3 |
| Sobolewska, A | 4 |
| Skórzewska, A | 4 |
| Płaźnik, A | 3 |
| Fischer, DK | 1 |
| Rice, RC | 1 |
| Martinez Rivera, A | 1 |
| Donohoe, M | 1 |
| Rajadhyaksha, AM | 1 |
| Segat, HJ | 2 |
| Barcelos, RCS | 2 |
| Metz, VG | 1 |
| Rosa, HZ | 2 |
| Roversi, K | 5 |
| Antoniazzi, CTD | 1 |
| Vey, LT | 4 |
| Kronbauer, M | 2 |
| Veit, JC | 2 |
| Piccolo, JC | 1 |
| Emanuelli, T | 2 |
| Burger, ME | 4 |
| Bananej, A | 1 |
| Völkl-Kernstock, S | 1 |
| Lesch, O | 1 |
| Walter, H | 1 |
| Skala, K | 1 |
| Liu, J | 1 |
| Scira, J | 1 |
| Donaldson, S | 1 |
| Kajiji, N | 1 |
| Dash, GH | 1 |
| Donaldson, ST | 1 |
| Richetto, J | 1 |
| Polesel, M | 1 |
| Weber-Stadlbauer, U | 1 |
| Rincón-Cortés, M | 1 |
| Gagnon, KG | 1 |
| Dollish, HK | 1 |
| Grace, AA | 2 |
| Giovanoli, S | 1 |
| Werge, TM | 1 |
| Mortensen, PB | 1 |
| Didriksen, M | 1 |
| Meyer, U | 1 |
| Loiodice, S | 1 |
| Wing Young, H | 1 |
| Rion, B | 1 |
| Méot, B | 1 |
| Montagne, P | 1 |
| Denibaud, AS | 1 |
| Viel, R | 1 |
| Drieu La Rochelle, C | 1 |
| Lai, CW | 1 |
| Chang, CH | 1 |
| Dias, VT | 2 |
| D'avila, LF | 1 |
| Kołosowska, K | 1 |
| Gawryluk, A | 1 |
| Liguz-Lęcznar, M | 1 |
| Hetmańczyk, K | 1 |
| Ługowska, A | 1 |
| Du, Y | 1 |
| Koltunowska, D | 2 |
| Gibula-Bruzda, E | 2 |
| Kotlinska, JH | 2 |
| Schmidt, MJ | 1 |
| Horvath, S | 1 |
| Ebert, P | 1 |
| Norris, JL | 1 |
| Seeley, EH | 1 |
| Brown, J | 1 |
| Gellert, L | 1 |
| Everheart, M | 1 |
| Garbett, KA | 1 |
| Grice, TW | 1 |
| Caprioli, RM | 1 |
| Mirnics, K | 1 |
| Gil-Ad, I | 1 |
| Portnoy, M | 1 |
| Tarasenko, I | 1 |
| Bidder, M | 1 |
| Kramer, M | 1 |
| Taler, M | 1 |
| Weizman, A | 1 |
| Schuster, AJ | 1 |
| Pase, CS | 2 |
| Antoniazzi, CT | 1 |
| Schmidt, KT | 1 |
| Weinshenker, D | 1 |
| Yu, Q | 1 |
| Teixeira, CM | 1 |
| Mahadevia, D | 1 |
| Huang, Y | 1 |
| Balsam, D | 1 |
| Mann, JJ | 1 |
| Gingrich, JA | 1 |
| Ansorge, MS | 1 |
| McLelland, AE | 1 |
| Martin-Iverson, MT | 1 |
| Beninger, RJ | 2 |
| Mabrouk, OS | 1 |
| Dripps, IJ | 1 |
| Ramani, S | 1 |
| Chang, C | 1 |
| Han, JL | 1 |
| Rice, KC | 1 |
| Jutkiewicz, EM | 1 |
| Toledano, D | 2 |
| Gisquet-Verrier, P | 2 |
| Reinbold, ED | 1 |
| Oliver, KM | 2 |
| Lehner, MH | 2 |
| Taracha, E | 2 |
| Kaniuga, E | 2 |
| Wróbel, J | 1 |
| Tu, W | 1 |
| Cook, A | 1 |
| Mears, M | 1 |
| Lin, SH | 1 |
| Chien, YC | 1 |
| Chiang, WW | 1 |
| Liu, YZ | 1 |
| Lien, CC | 1 |
| Chen, CC | 1 |
| Fulde, GW | 1 |
| Forster, SL | 1 |
| Kuhn, FT | 1 |
| de Freitas, DL | 1 |
| Fukushiro, DF | 1 |
| Olivera, A | 1 |
| Liu, Y | 1 |
| Wang, Z | 1 |
| Kirkpatrick, MG | 1 |
| Goldenson, NI | 1 |
| Kapadia, N | 1 |
| Kahler, CW | 1 |
| de Wit, H | 2 |
| Swift, RM | 1 |
| McGeary, JE | 1 |
| Sussman, S | 1 |
| Leventhal, AM | 1 |
| Xu, M | 2 |
| Li, L | 1 |
| Pittenger, C | 1 |
| Gentile, A | 1 |
| Fresegna, D | 1 |
| Musella, A | 1 |
| Sepman, H | 1 |
| Bullitta, S | 1 |
| De Vito, F | 1 |
| Fantozzi, R | 1 |
| Usiello, A | 1 |
| Maccarrone, M | 1 |
| Mercuri, NB | 1 |
| Lutz, B | 1 |
| Mandolesi, G | 1 |
| Centonze, D | 1 |
| Gatica, RI | 1 |
| Pérez-Valenzuela, E | 1 |
| Sierra-Mercado, D | 1 |
| Fuentealba, JA | 1 |
| Cartabuke, RS | 1 |
| Tobias, JD | 1 |
| Rice, J | 1 |
| Tumin, D | 1 |
| Gonzáles, MA | 1 |
| Miranda, AP | 1 |
| Orrego, H | 1 |
| Silva, R | 1 |
| Forray, MI | 1 |
| Bespalov, AY | 1 |
| van Gaalen, MM | 1 |
| Sukhotina, IA | 1 |
| Wicke, K | 1 |
| Mezler, M | 1 |
| Schoemaker, H | 1 |
| Gross, G | 1 |
| Barbier, E | 1 |
| Pierrefiche, O | 1 |
| Vaudry, D | 1 |
| Vaudry, H | 1 |
| Daoust, M | 1 |
| Naassila, M | 1 |
| Luuk, H | 1 |
| Plaas, M | 1 |
| Raud, S | 1 |
| Innos, J | 1 |
| Sütt, S | 1 |
| Lasner, H | 1 |
| Abramov, U | 1 |
| Kurrikoff, K | 1 |
| Kõks, S | 1 |
| Vasar, E | 1 |
| Willi, R | 1 |
| Aloy, EM | 1 |
| Yee, BK | 2 |
| Feldon, J | 3 |
| Schwab, ME | 1 |
| Kelly, MP | 1 |
| Logue, SF | 1 |
| Dwyer, JM | 1 |
| Beyer, CE | 1 |
| Majchrowski, H | 1 |
| Cai, Z | 1 |
| Liu, Z | 1 |
| Adedoyin, A | 1 |
| Rosenzweig-Lipson, S | 1 |
| Comery, TA | 1 |
| Ennaceur, A | 2 |
| Michalikova, S | 1 |
| van Rensburg, R | 1 |
| Chazot, PL | 1 |
| Vuong, SM | 1 |
| Oliver, HA | 1 |
| Rotllant, D | 1 |
| Márquez, C | 1 |
| Nadal, R | 1 |
| Armario, A | 1 |
| Barr, JL | 1 |
| Black, MD | 1 |
| Stevens, RJ | 1 |
| Rogacki, N | 1 |
| Featherstone, RE | 1 |
| Senyah, Y | 1 |
| Giardino, O | 1 |
| Borowsky, B | 2 |
| Stemmelin, J | 1 |
| Cohen, C | 1 |
| Pichat, P | 1 |
| Arad, M | 1 |
| Barak, S | 1 |
| De Levie, A | 1 |
| Weiner, I | 1 |
| Griebel, G | 1 |
| Varty, GB | 1 |
| Iezhitsa, IN | 1 |
| Spasov, AA | 1 |
| Kharitonova, MV | 1 |
| Kravchenko, MS | 1 |
| Bailer, UF | 1 |
| Narendran, R | 1 |
| Frankle, WG | 1 |
| Himes, ML | 1 |
| Duvvuri, V | 1 |
| Mathis, CA | 1 |
| Kaye, WH | 1 |
| Muhammad, A | 1 |
| Kolb, B | 1 |
| Shabanov, PD | 1 |
| Lebedev, AA | 1 |
| Labonte, B | 1 |
| McLaughlin, RJ | 1 |
| Dominguez-Lopez, S | 1 |
| Bambico, FR | 1 |
| Lucchino, I | 1 |
| Ochoa-Sanchez, R | 1 |
| Leyton, M | 1 |
| Gobbi, G | 1 |
| Raoof, H | 1 |
| Suder, P | 1 |
| Silberring, J | 1 |
| Erreger, K | 1 |
| Davis, AR | 1 |
| Poe, AM | 1 |
| Greig, NH | 1 |
| Stanwood, GD | 1 |
| Galli, A | 1 |
| Sandau, US | 1 |
| Alderman, Z | 1 |
| Corfas, G | 2 |
| Ojeda, SR | 1 |
| Raber, J | 1 |
| Latapy, C | 1 |
| Rioux, V | 1 |
| Guitton, MJ | 1 |
| Beaulieu, JM | 1 |
| Bannerman, DM | 1 |
| Grubb, M | 1 |
| Deacon, RM | 1 |
| Rawlins, JN | 1 |
| van den Buuse, M | 2 |
| LEHEW, JL | 1 |
| GRAHN, HV | 1 |
| COBBIN, LB | 1 |
| LAWSON, PT | 1 |
| MCFADYEN, R | 1 |
| LANZETTA, JT | 1 |
| WENDT, GR | 1 |
| LANGHAM, P | 1 |
| HAEFNER, D | 1 |
| SCHOPBACH, RR | 1 |
| SETTEL, E | 1 |
| CALDWELL, WG | 1 |
| NOWERS, W | 1 |
| CUPARENCU, B | 1 |
| GROSU, L | 1 |
| DAMACUS, M | 1 |
| FEIGLEY, DM | 1 |
| BEECHER, HK | 1 |
| SMITH, GM | 1 |
| PFEIFFER, CC | 1 |
| GOLDSTEIN, L | 1 |
| WEITZNER, M | 1 |
| Wood, GK | 1 |
| Quirion, R | 2 |
| Srivastava, LK | 2 |
| Hohoff, C | 1 |
| McDonald, JM | 1 |
| Baune, BT | 1 |
| Cook, EH | 1 |
| Deckert, J | 1 |
| Russig, H | 1 |
| Murphy, CA | 1 |
| Cassidy, CM | 1 |
| Mällo, T | 1 |
| Alttoa, A | 1 |
| Kõiv, K | 1 |
| Tõnissaar, M | 1 |
| Eller, M | 1 |
| Harro, J | 2 |
| Wolinsky, TD | 1 |
| Swanson, CJ | 1 |
| Smith, KE | 1 |
| Zhong, H | 1 |
| Seeman, P | 1 |
| Branchek, T | 1 |
| Gerald, CP | 1 |
| Robbins, MJ | 1 |
| Starr, KR | 1 |
| Honey, A | 1 |
| Soffin, EM | 1 |
| Rourke, C | 1 |
| Jones, GA | 1 |
| Kelly, FM | 1 |
| Strum, J | 1 |
| Melarange, RA | 1 |
| Harris, AJ | 1 |
| Rocheville, M | 1 |
| Rupniak, T | 1 |
| Murdock, PR | 1 |
| Jones, DN | 2 |
| Kew, JN | 1 |
| Maycox, PR | 1 |
| Roy, K | 1 |
| Murtie, JC | 1 |
| El-Khodor, BF | 1 |
| Edgar, N | 1 |
| Sardi, SP | 1 |
| Hooks, BM | 1 |
| Benoit-Marand, M | 1 |
| Chen, C | 1 |
| Moore, H | 1 |
| O'Donnell, P | 1 |
| Brunner, D | 1 |
| Angel, C | 1 |
| Murphree, OD | 1 |
| DeLuca, DC | 1 |
| Bilkei-Gorzó, A | 1 |
| Otto, M | 1 |
| Zimmer, A | 1 |
| Siuciak, JA | 1 |
| McCarthy, SA | 1 |
| Chapin, DS | 1 |
| Martin, AN | 1 |
| Harms, JF | 1 |
| Schmidt, CJ | 1 |
| Kuan, WL | 1 |
| Zhao, JW | 1 |
| Barker, RA | 1 |
| Featherby, T | 1 |
| Lubman, DI | 1 |
| Lawrence, AJ | 1 |
| Seelye, EE | 1 |
| Salt, JS | 1 |
| Taberner, PV | 1 |
| deWit, H | 1 |
| Johanson, CE | 1 |
| Uhlenhuth, EH | 1 |
| McCracken, S | 1 |
| Milkman, H | 2 |
| Frosch, W | 1 |
| Perry, W | 1 |
| Sprock, J | 1 |
| Schaible, D | 1 |
| McDougall, A | 1 |
| Minassian, A | 1 |
| Jenkins, M | 1 |
| Braff, D | 1 |
| Lapin, IP | 1 |
| Borisenko, SA | 1 |
| Meng, QH | 1 |
| Rauhala, P | 1 |
| Männistö, PT | 1 |
| Koeltzow, TE | 1 |
| Santiago, GT | 1 |
| Moratalla, R | 1 |
| Cooper, DC | 1 |
| Hu, XT | 1 |
| White, NM | 1 |
| Graybiel, AM | 1 |
| White, FJ | 1 |
| Tonegawa, S | 1 |
| Otter, MH | 1 |
| Matto, V | 1 |
| Sõukand, R | 1 |
| Skrebuhhova, T | 1 |
| Allikmets, L | 1 |
| Will, MJ | 1 |
| Watkins, LR | 1 |
| Maier, SF | 1 |
| Lin, HQ | 1 |
| Burden, PM | 1 |
| Christie, MJ | 1 |
| Johnston, GA | 1 |
| Leri, F | 1 |
| Franklin, KB | 1 |
| Dringenberg, HC | 1 |
| Wightman, M | 1 |
| Cancela, LM | 1 |
| Basso, AM | 1 |
| Martijena, ID | 1 |
| Capriles, NR | 1 |
| Molina, VA | 1 |
| File, SE | 1 |
| Hyde, JR | 1 |
| Woody, GE | 1 |
| O'Brien, CP | 1 |
| Rickels, K | 1 |
| Saletu, B | 1 |
| Saletu, M | 1 |
| Simeon, J | 1 |
| Viamontes, G | 1 |
| Itil, TM | 1 |
| Laviola, G | 1 |
| Pick, CG | 1 |
| Yanai, J | 1 |
| Alleva, E | 1 |
| Carey, GJ | 1 |
| Costall, B | 1 |
| Domeney, AM | 1 |
| Naylor, RJ | 1 |
| Bennett, G | 1 |
| Rigby, K | 1 |
| Koella, WP | 1 |
| Tibilova, AU | 1 |
| Alimova, RA | 1 |
| Fowler, B | 1 |
| Ackles, KN | 1 |
| Porlier, G | 1 |
| Kinsbourne, M | 1 |
| Rardin, DR | 1 |
| Lawson, TR | 1 |
| Kruzich, DJ | 1 |
| Schnee, J | 1 |
| Ginet, J | 1 |
| Levy, JC | 1 |
| Rolland, D | 1 |
| Heller, ME | 1 |
| Mordkoff, AM | 1 |
| Henriques, E | 1 |
| Arsenian, J | 1 |
| Cutter, H | 1 |
| Samaraweera, AB | 1 |
| Kipperman, A | 1 |
| Fine, EW | 1 |
| Schildkraut, JJ | 1 |
| Wallace, D | 1 |
| Hiner, D | 1 |
| Enelow, AJ | 1 |
| Kielholz, P | 1 |
| Levy, RM | 1 |
| Brown, AR | 1 |
| Halikas, JA | 1 |
| Cappell, H | 1 |
| Ginsberg, R | 1 |
| Webster, CD | 1 |
| Arnold, LE | 1 |
| Strobl, D | 1 |
| Weisenberg, A | 1 |
| Dow, TW | 1 |
| Silver, D | 1 |
| Frosch, WA | 1 |
| Müller-Oswald, U | 1 |
| Ruppen, R | 1 |
| Baumann, U | 1 |
| Angst, J | 1 |
| Nail, RL | 1 |
| Gunderson, EK | 1 |
| Kolb, D | 1 |
| Goldstein, BJ | 1 |
| Brauzer, B | 1 |
| Simon, P | 2 |
| Howell, MC | 1 |
| Rever, GW | 1 |
| Scholl, ML | 1 |
| Trowbridge, F | 1 |
| Rutledge, A | 1 |
| Juve, JL | 1 |
| Boissier, JR | 1 |
| Cockett, R | 1 |
| Marks, V | 1 |
| Jackson, B | 1 |
| Reed, A | 1 |
| Prokop, H | 1 |
| Blackman, D | 1 |
7 reviews available for amphetamine and Anxiety
| Article | Year |
|---|---|
Adrenaline rush: the role of adrenergic receptors in stimulant-induced behaviors.
Topics: Amphetamine; Animals; Anxiety; Avoidance Learning; Behavior, Addictive; Behavior, Animal; Central Ne | 2014 |
The impact of amphetamine-type stimulants on emergency services.
Topics: Acute Disease; Aggression; Amphetamine; Amphetamine-Related Disorders; Anxiety; Central Nervous Syst | 2015 |
CNS-related (side-)effects of beta-blockers with special reference to mechanisms of action.
Topics: Adrenergic beta-Antagonists; Amphetamine; Animals; Anxiety; Blood-Brain Barrier; Central Nervous Sys | 1985 |
The use and abuse of the psychotropic drugs.
Topics: Adult; Amphetamine; Antidepressive Agents; Anxiety; Chlorpromazine; Depression; Drug Utilization; Fe | 1973 |
[Psychopharmacologic drugs in dentistry and drug dependency].
Topics: Amphetamine; Amphetamines; Antidepressive Agents; Anxiety; Humans; Hypnotics and Sedatives; Phenacet | 1974 |
Pharmacologic considerations in the treatment of anxiety and depression in medical practice.
Topics: Adult; Amphetamine; Antidepressive Agents; Anxiety; Autonomic Nervous System; Cardiovascular System; | 1971 |
[Tranquilizing agents. Possibilities for animal studies].
Topics: Aggression; Amphetamine; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Brain; Conflict, | 1970 |
5 trials available for amphetamine and Anxiety
| Article | Year |
|---|---|
Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants.
Topics: Adolescent; Adult; Amphetamine; Anxiety; Central Nervous System Stimulants; Dose-Response Relationsh | 2005 |
Amphetamine on Rorschach measures in normal subjects.
Topics: Adult; Amphetamine; Anxiety; Blood Pressure; Double-Blind Method; Humans; Male; Placebos; Rorschach | 1995 |
Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone.
Topics: Administration, Oral; Adult; Alcoholic Intoxication; Amphetamine; Anxiety; Barbiturates; Capsules; C | 1975 |
Comparative symptomatological and evoked potential studies with d-amphetamine, thioridazine, and placebo in hyperkinetic children.
Topics: Administration, Oral; Adolescent; Amphetamine; Anxiety; Child; Child Behavior; Clinical Trials as To | 1975 |
Hyperkinetic adult. Study of the "paradoxical" amphetamine response.
Topics: Adult; Age Factors; Amphetamine; Anxiety; Depression; Dextroamphetamine; Humans; Hyperkinesis; Male; | 1972 |
126 other studies available for amphetamine and Anxiety
| Article | Year |
|---|---|
Chronic administration of glucocorticoid receptor ligands increases anxiety-like behavior and selectively increase serotonin transporters in the ventral hippocampus.
Topics: Amphetamine; Animals; Anxiety; Corticosterone; Hippocampus; Hypothalamo-Hypophyseal System; Male; Mi | 2023 |
Chronic administration of glucocorticoid receptor ligands increases anxiety-like behavior and selectively increase serotonin transporters in the ventral hippocampus.
Topics: Amphetamine; Animals; Anxiety; Corticosterone; Hippocampus; Hypothalamo-Hypophyseal System; Male; Mi | 2023 |
Chronic administration of glucocorticoid receptor ligands increases anxiety-like behavior and selectively increase serotonin transporters in the ventral hippocampus.
Topics: Amphetamine; Animals; Anxiety; Corticosterone; Hippocampus; Hypothalamo-Hypophyseal System; Male; Mi | 2023 |
Chronic administration of glucocorticoid receptor ligands increases anxiety-like behavior and selectively increase serotonin transporters in the ventral hippocampus.
Topics: Amphetamine; Animals; Anxiety; Corticosterone; Hippocampus; Hypothalamo-Hypophyseal System; Male; Mi | 2023 |
Clavulanic Acid Improves Memory Dysfunction and Anxiety Behaviors through Upregulating Glutamatergic Transporters in the Nucleus Accumbens of Mice Repeatedly Exposed to Khat Extract.
Topics: Amphetamine; Animals; Anxiety; Catha; Clavulanic Acid; Memory Disorders; Mice; Nucleus Accumbens; Ra | 2023 |
5-HT1A and α2 adrenergic receptor levels are associated with high anxiety-like patterns and impulsivity in selectively bred Long Evans rats.
Topics: Adrenergic Agents; Amphetamine; Animals; Anxiety; Behavior, Animal; Brain; Conditioning, Operant; El | 2020 |
Kava decreases the stereotyped behavior induced by amphetamine in mice.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Kava; Locomotion; Male; Maze L | 2021 |
The amphetamine-associated context exerts a stronger motivational effect in low-anxiety rats than in high-anxiety rats.
Topics: Amphetamine; Amphetamines; Amygdala; Animals; Anxiety; Anxiety Disorders; Behavior, Animal; Conditio | 2017 |
Altered reward sensitivity in female offspring of cocaine-exposed fathers.
Topics: Amphetamine; Animals; Anxiety; Central Nervous System Stimulants; Cocaine; Dopamine Uptake Inhibitor | 2017 |
Influence of physical activity on addiction parameters of rats exposed to amphetamine which were previously supplemented with hydrogenated vegetable fat.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Brain; Cerebral Cort | 2017 |
No evidence of subgroups found in amphetamine consumers in Iran.
Topics: Amphetamine; Anxiety; Depression; Drug Users; Humans; Iran; Substance-Related Disorders | 2018 |
Sex and Trait Anxiety Differences in Psychological Stress are Modified by Environment.
Topics: Amphetamine; Animals; Anxiety; Central Nervous System Stimulants; Female; Habituation, Psychophysiol | 2018 |
Effects of light and dark phase testing on the investigation of behavioural paradigms in mice: Relevance for behavioural neuroscience.
Topics: Amphetamine; Animals; Anxiety; Behavior, Animal; Circadian Rhythm; Cohort Studies; Dopamine Plasma M | 2019 |
Diazepam reverses increased anxiety-like behavior, social behavior deficit, and dopamine dysregulation following withdrawal from acute amphetamine.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anxiety; Central Nervous System Stimulants; Diazepam; Dop | 2018 |
Interactive effects between hemizygous 15q13.3 microdeletion and peripubertal stress on adult behavioral functions.
Topics: Age Factors; Amphetamine; Anhedonia; Animals; Anxiety; Behavior, Animal; Central Nervous System Stim | 2019 |
Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson's disease.
Topics: Amphetamine; Animals; Antiparkinson Agents; Anxiety; Benserazide; Disease Models, Animal; Dopamine; | 2019 |
Adaptive anxious states and down-regulation of dopamine activity under amygdala activation in rats.
Topics: Amphetamine; Amygdala; Animals; Anxiety; Dopamine; Dopaminergic Neurons; Down-Regulation; Male; Moto | 2019 |
Modafinil reduces amphetamine preference and prevents anxiety-like symptoms during drug withdrawal in young rats: Involvement of dopaminergic targets in VTA and striatum.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Central Nervous System Stimulants; Cor | 2019 |
Stress changes amphetamine response, D2 receptor expression and epigenetic regulation in low-anxiety rats.
Topics: Amphetamine; Animals; Anxiety; Dentate Gyrus; Disease Models, Animal; Epigenesis, Genetic; Fear; Hip | 2019 |
Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia.
Topics: Amphetamine; Animals; Anxiety; Central Nervous System Sensitization; Diazepam; Dopaminergic Neurons; | 2013 |
The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.
Topics: Acamprosate; Amphetamine; Animals; Anxiety; Bridged Bicyclo Compounds; Dose-Response Relationship, D | 2013 |
Modulation of behavioral networks by selective interneuronal inactivation.
Topics: Amphetamine; Animals; Anxiety; Behavior; Brain; Central Nervous System Stimulants; Cholecystokinin; | 2014 |
A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia.
Topics: Alanine; Amphetamine; Animals; Antipsychotic Agents; Anxiety; Benzodiazepines; Brain; Central Nervou | 2014 |
Exercise modifies amphetamine relapse: behavioral and oxidative markers in rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Biomarkers; Catalase; Conditioning, Ps | 2014 |
Dopamine and serotonin signaling during two sensitive developmental periods differentially impact adult aggressive and affective behaviors in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Affect; Aggression; Amphetamine; Animals; Anxiety; Brain; Central Ne | 2014 |
The effect of quetiapine (Seroquel™) on conditioned place preference and elevated plus maze tests in rats when administered alone and in combination with (+)-amphetamine.
Topics: Amphetamine; Animals; Antipsychotic Agents; Anxiety; Behavior, Animal; Central Nervous System Stimul | 2014 |
Automated touch screen device for recording complex rodent behaviors.
Topics: Actigraphy; Amphetamine; Analgesics, Opioid; Animals; Anxiety; Behavior, Animal; Benzamides; Biomech | 2014 |
Only susceptible rats exposed to a model of PTSD exhibit reactivity to trauma-related cues and other symptoms: an effect abolished by a single amphetamine injection.
Topics: Amphetamine; Animals; Anxiety; Cues; Disease Models, Animal; Genetic Predisposition to Disease; Indi | 2014 |
Central CRF2 receptor antagonism reduces anxiety states during amphetamine withdrawal.
Topics: Amphetamine; Animals; Anxiety; Infusions, Intraventricular; Male; Motor Activity; Peptide Fragments; | 2014 |
High-anxiety rats are less sensitive to the rewarding affects of amphetamine on 50kHz USV.
Topics: Amphetamine; Analysis of Variance; Animals; Anxiety; Central Nervous System Stimulants; Conditioning | 2014 |
Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal.
Topics: 5,7-Dihydroxytryptamine; Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Central Nervo | 2014 |
Genetic mapping of ASIC4 and contrasting phenotype to ASIC1a in modulating innate fear and anxiety.
Topics: Acid Sensing Ion Channels; Amphetamine; Animals; Anxiety; Body Composition; Eating; Estrogen Antagon | 2015 |
Cross-Generational trans Fat Consumption Favors Self-Administration of Amphetamine and Changes Molecular Expressions of BDNF, DAT, and D1/D2 Receptors in the Cortex and Hippocampus of Rats.
Topics: Amphetamine; Animals; Anxiety; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Dopamine Plasma M | 2015 |
Neonatal exposure to amphetamine alters social affiliation and central dopamine activity in adult male prairie voles.
Topics: Amphetamine; Analysis of Variance; Animals; Animals, Newborn; Anxiety; Arvicolinae; Body Weight; Cen | 2015 |
Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers.
Topics: Adult; Affect; Amphetamine; Anxiety; Arousal; Central Nervous System Stimulants; Dextroamphetamine; | 2016 |
Repeated amphetamine injections alter behavior and induce a delayed behavioral sensitization modulated by reactivity to novelty: Similarities and differences with trauma consequences.
Topics: Adaptation, Ocular; Amphetamine; Analysis of Variance; Animals; Anxiety; Avoidance Learning; Central | 2016 |
Ablation of fast-spiking interneurons in the dorsal striatum, recapitulating abnormalities seen post-mortem in Tourette syndrome, produces anxiety and elevated grooming.
Topics: Amphetamine; Animals; Anxiety; Central Nervous System Stimulants; Conditioning, Psychological; Corpu | 2016 |
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis.
Topics: Amphetamine; Animals; Antirheumatic Agents; Anxiety; Central Nervous System Stimulants; Cerebral Cor | 2016 |
Low-anxiety rats are more sensitive to amphetamine in comparison to high-anxiety rats.
Topics: Amphetamine; Animals; Anxiety; Anxiety Disorders; Behavior, Animal; Conditioning, Classical; Conditi | 2017 |
The expression of amphetamine sensitization is dissociable from anxiety and aversive memory: Effect of an acute injection of amphetamine.
Topics: Amphetamine; Animals; Anxiety; Avoidance Learning; Central Nervous System Stimulants; Male; Memory; | 2017 |
Hemodynamic profile and behavioral characteristics during induction of anesthesia in pediatric patients with attention deficit hyperactivity disorder.
Topics: Adolescent; Amphetamine; Anesthesia; Anti-Anxiety Agents; Anxiety; Attention Deficit Disorder with H | 2017 |
Enduring attenuation of norepinephrine synaptic availability and augmentation of the pharmacological and behavioral effects of desipramine by repeated immobilization stress.
Topics: Amphetamine; Animals; Antidepressive Agents, Tricyclic; Anxiety; Central Nervous System Stimulants; | 2017 |
Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression.
Topics: Amino Acids; Amphetamine; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; An | 2008 |
Long-term alterations in vulnerability to addiction to drugs of abuse and in brain gene expression after early life ethanol exposure.
Topics: Amphetamine; Animals; Anxiety; Avoidance Learning; Brain Chemistry; Central Nervous System Depressan | 2008 |
Wfs1-deficient mice display impaired behavioural adaptation in stressful environment.
Topics: Adaptation, Psychological; Amphetamine; Animals; Anxiety; Apomorphine; Central Nervous System Stimul | 2009 |
Behavioral characterization of mice lacking the neurite outgrowth inhibitor Nogo-A.
Topics: Amphetamine; Animals; Anxiety; Association Learning; Avoidance Learning; Behavior, Animal; Central N | 2009 |
The supra-additive hyperactivity caused by an amphetamine-chlordiazepoxide mixture exhibits an inverted-U dose response: negative implications for the use of a model in screening for mood stabilizers.
Topics: Affect; Amphetamine; Animals; Antimanic Agents; Anxiety; Bipolar Disorder; Chlordiazepoxide; Disease | 2009 |
Distinguishing anxiolysis and hyperactivity in an open space behavioral test.
Topics: Amphetamine; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Central | 2010 |
Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism.
Topics: Amphetamine; Animals; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Male; Maze Learn | 2010 |
The brain pattern of c-fos induction by two doses of amphetamine suggests different brain processing pathways and minor contribution of behavioural traits.
Topics: Amphetamine; Animals; Anxiety; Brain; Central Nervous System Stimulants; Exploratory Behavior; Facto | 2010 |
Withdrawal from chronic amphetamine produces persistent anxiety-like behavior but temporally-limited reductions in monoamines and neurogenesis in the adult rat dentate gyrus.
Topics: Amphetamine; Analysis of Variance; Animals; Anxiety; Cell Count; Cell Death; Corticosterone; Dentate | 2010 |
AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents.
Topics: Acoustic Stimulation; Amphetamine; Animals; Antipsychotic Agents; Anxiety; Behavior, Animal; Catalep | 2011 |
Effect of magnesium chloride on psychomotor activity, emotional status, and acute behavioural responses to clonidine, d-amphetamine, arecoline, nicotine, apomorphine, and L-5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Anxiety; Apomorphine; Arecoline; Clonidine; Depression; D | 2011 |
Amphetamine induced dopamine release increases anxiety in individuals recovered from anorexia nervosa.
Topics: Adult; Amphetamine; Anorexia Nervosa; Anxiety; Corpus Striatum; Dopamine; Dopamine Agents; Euphoria; | 2012 |
Mild prenatal stress-modulated behavior and neuronal spine density without affecting amphetamine sensitization.
Topics: Amphetamine; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Dendritic Spines; Disease Mod | 2011 |
[Behavioral correlations of gradual forced administration of psychoactive drugs].
Topics: Amphetamine; Animals; Anxiety; Behavior, Animal; Dexamethasone; Dose-Response Relationship, Drug; Dr | 2011 |
Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood.
Topics: Amphetamine; Animals; Anxiety; Behavior, Animal; Biogenic Monoamines; Central Nervous System Stimula | 2012 |
Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine-induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats.
Topics: Adamantane; Amphetamine; Animals; Anxiety; Behavior, Animal; Conditioning, Psychological; Dipeptides | 2012 |
Open space anxiety test in rodents: the elevated platform with steep slopes.
Topics: Altitude; Amphetamine; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Behavior, Animal; | 2012 |
Exendin-4 decreases amphetamine-induced locomotor activity.
Topics: Amphetamine; Animals; Antimanic Agents; Anxiety; Central Nervous System Stimulants; Conditioning, Op | 2012 |
Astrocyte-specific disruption of SynCAM1 signaling results in ADHD-like behavioral manifestations.
Topics: Amphetamine; Animals; Anxiety; Astrocytes; Attention Deficit Disorder with Hyperactivity; Behavior, | 2012 |
Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anxiety; Enzyme Activation; Female; Gene Deletion; Gene S | 2012 |
Ventral hippocampal lesions affect anxiety but not spatial learning.
Topics: Amphetamine; Analysis of Variance; Animals; Anxiety; Discrimination Learning; Fear; Feeding Behavior | 2003 |
Deficient prepulse inhibition of acoustic startle in Hooded-Wistar rats compared with Sprague-Dawley rats.
Topics: Acoustic Stimulation; Amphetamine; Animals; Anxiety; Apomorphine; Disease Models, Animal; Dizocilpin | 2003 |
Evaluation of an amphetamine-barbiturate combination in the supportive treatment of the aged.
Topics: Aged; Amphetamine; Amphetamines; Anxiety; Barbiturates; Depression; Depressive Disorder; Humans | 1954 |
Use of a d-amphetamine-amobarbital combination as an adjunct to the treatment of carcinoma.
Topics: Amobarbital; Amphetamine; Amphetamines; Anxiety; Barbiturates; Depression; Depressive Disorder; Dext | 1954 |
An apparatus for the study of the effects of central nervous stimulants on the spontaneous activity of small laboratory animals.
Topics: Amphetamine; Amphetamines; Animals; Animals, Laboratory; Anxiety; Central Nervous System; Central Ne | 1955 |
The effects of an anxiety-reducing medication on group behavior under threat.
Topics: Amphetamine; Amphetamines; Anxiety; Anxiety Disorders; Barbiturates; Behavior; Humans | 1956 |
Anxiety and its pharmacologic control.
Topics: Amphetamine; Amphetamines; Anxiety; Anxiety Disorders; Humans; Tranquilizing Agents | 1957 |
Dextro-amphetamine sulfate in mild depression and anxiety.
Topics: Amphetamine; Amphetamines; Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Dextroamphet | 1957 |
Prepartum depression; a study of seventy unwed mothers treated with d-amphetamine sulfate and amobarbital.
Topics: Amobarbital; Amphetamine; Amphetamines; Anxiety; Apathy; Depression; Depressive Disorder; Dextroamph | 1958 |
The influence of certain drugs with a predominant central nervous action on protein assimilation and disassimilation.
Topics: Amphetamine; Amphetamines; Anxiety; Barbiturates; Chlorpromazine; Humans; Picrotoxin; Proteins | 1961 |
Office care of mild emotional distress.
Topics: Amobarbital; Amphetamine; Amphetamines; Anxiety; Anxiety Disorders; Atropa belladonna; Depression; D | 1962 |
THE FUTURE OF TRANQUILIZER RESEARCH AND THE THERAPY OF ANXIETY. THE NEED FOR A QUANTITATIVE APPROACH TO THE STUDY OF "DEPRESSANT TRANQUILIZERS".
Topics: Amphetamine; Amphetamines; Anxiety; Anxiety Disorders; Drug Therapy; Hypnotics and Sedatives; Morphi | 1964 |
PANEL DISCUSSION. 3. THE FUTURE OF TRANQUILIZER RESEARCH AND THE THERAPY OF ANXIETY. ASSAY OF ANTI-ANXIETY DRUGS BY QUANTITATIVE ELECTROENCEPHALOGRAPHY.
Topics: Alcohols; Amphetamine; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Biomedical Research; Chlordi | 1964 |
MANIFEST ANXIETY, AMPHETAMINE, AND PERFORMANCE.
Topics: Amphetamine; Amphetamines; Anxiety; Anxiety Disorders; Humans; Motor Skills; Paired-Associate Learni | 1965 |
Early environment contributes to developmental disruption of MPFC after neonatal ventral hippocampal lesions in rats.
Topics: Amphetamine; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Dopamine Agents; Environment; Hip | 2003 |
Behavioural consequences of withdrawal from three different administration schedules of amphetamine.
Topics: Amphetamine; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Central Nervous System Stimul | 2005 |
Blockade of presynaptic voltage-gated calcium channels in the medial prefrontal cortex of neonatal rats leads to post-pubertal alterations in locomotor behavior.
Topics: Aging; Amphetamine; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Calcium Channel Blockers; | 2006 |
Rats with persistently low or high exploratory activity: behaviour in tests of anxiety and depression, and extracellular levels of dopamine.
Topics: Amphetamine; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Central Nervous System Stimul | 2007 |
The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia.
Topics: Amphetamine; Animals; Anxiety; Behavior, Animal; Catecholamines; Central Nervous System Stimulants; | 2007 |
Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia.
Topics: Amphetamine; Animals; Anticonvulsants; Anxiety; Autoreceptors; Benzoates; Brain; Central Nervous Sys | 2007 |
Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders.
Topics: Amphetamine; Animals; Anxiety; Cyclic Nucleotide Phosphodiesterases, Type 1; Dopamine; ErbB Receptor | 2007 |
The effects of chlordiazepoxide, amphetamine and cocaine on bar-press behavior in normal and genetically nervous dogs.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Chlordiazepoxide; Cocaine; Con | 1974 |
Environmental modulation of anxiety-related neuronal activity and behaviors.
Topics: Amphetamine; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Central Nervous System Stimul | 2008 |
Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57/Bl6N congenic background.
Topics: Amphetamine; Animals; Anxiety; Avoidance Learning; Behavior, Animal; Biogenic Monoamines; Brain Chem | 2008 |
The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram.
Topics: Adrenal Cortex Hormones; Amphetamine; Animals; Anxiety; Blotting, Western; Body Weight; Central Nerv | 2008 |
Persistent downregulation of hippocampal CREB mRNA parallels a Y-maze deficit in adolescent rats following semi-chronic amphetamine administration.
Topics: Age Factors; Amphetamine; Animals; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Cyc | 2008 |
Successful treatment of amphetamine addiction in a schizophrenic woman.
Topics: Adult; Amphetamine; Anticonvulsants; Anxiety; Depression; Electroconvulsive Therapy; Female; Humans; | 1967 |
Differential effects of benzodiazepines and amphetamine on exploratory behaviour in weanling rats: an animal model for anxiolytic activity.
Topics: Amphetamine; Animals; Animals, Suckling; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Desipramine; | 1984 |
The effects of two nonpharmacological variables on drug preference in humans.
Topics: Adult; Amphetamine; Anxiety; Diazepam; Dose-Response Relationship, Drug; Emotions; Humans; Psycholog | 1983 |
Theory of drug use.
Topics: Adaptation, Psychological; Adult; Aggression; Amphetamine; Anxiety; Child; Child Development; Confli | 1980 |
Anxiogenic effect of phenylethylamine and amphetamine in the elevated plus-maze in mice and its attenuation by ethanol.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Dose-Response Relationship, Dr | 1993 |
Neurochemical mediators of anxiety have inconsistent effects on hypothalamic self-stimulation in rats.
Topics: Amphetamine; Animals; Antipsychotic Agents; Anxiety; Arousal; Central Nervous System Stimulants; Cer | 1996 |
Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors.
Topics: Amphetamine; Animals; Anxiety; Chimera; Cocaine; Conditioning, Operant; Crosses, Genetic; Cues; Dopa | 1997 |
Characterization of rat exploratory behavior using the exploration box test.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Buspirone; Carbolines; Diazepa | 1997 |
Uncontrollable stress potentiates morphine's rewarding properties.
Topics: Amphetamine; Animals; Anxiety; Carbolines; Central Nervous System Stimulants; Conditioning, Operant; | 1998 |
The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Dopamine Uptake Inhi | 1999 |
Diazepam modifies the effect of pedunculopontine lesions on morphine but not on amphetamine conditioned place preference.
Topics: Amphetamine; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Brain Injuries; Central Ne | 2000 |
The effects of amphetamine and raclopride on food transport: possible relation to defensive behavior in rats.
Topics: Amphetamine; Animals; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Dopamine Antagon | 2000 |
A dopaminergic mechanism is involved in the 'anxiogenic-like' response induced by chronic amphetamine treatment: a behavioral and neurochemical study.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Benzazepines; Brain; | 2001 |
A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anxiety; Caffeine; Central Nervous System Stimulants; Flu | 1979 |
Eight-arm maze performance, neophobia, and hippocampal cholinergic alterations after prenatal oxazepam in mice.
Topics: Amphetamine; Animals; Anxiety; Behavior, Animal; Dose-Response Relationship, Drug; Exploratory Behav | 1992 |
Behavioural effects of anxiogenic agents in the common marmoset.
Topics: Amphetamine; Animals; Anxiety; Behavior, Animal; Caffeine; Callithrix; Carbolines; Diazepam; Motor A | 1992 |
Psychological change during residence in a rehabilitation centre for female drug misusers. Part I. Drug misusers.
Topics: Adolescent; Adult; Amphetamine; Anxiety; Depression; Female; Heroin Dependence; Humans; Opioid-Relat | 1991 |
[Problem of transient dementias of old age (clinico-diagnostic aspect)].
Topics: Aged; Amphetamine; Anxiety; Central Nervous System Stimulants; Dementia; Depressive Disorder; Diagno | 1985 |
Effects of inert gas narcosis on behavior--a critical review.
Topics: Amphetamine; Animals; Anxiety; Arousal; Attention; Behavior; Blood Gas Analysis; Conditioning, Opera | 1985 |
School problems: diagnosis and treatment.
Topics: Agnosia; Amphetamine; Anxiety; Child; Child, Preschool; Cognition Disorders; Developmental Disabilit | 1973 |
Opiates, amphetamines, alcohol: a comparative study of American soldiers.
Topics: Adult; Alcoholism; Amphetamine; Anxiety; Authoritarianism; Boredom; Family Characteristics; Humans; | 1974 |
Pharmacological and dynamic factors in psychotropic drug therapy.
Topics: Adult; Amphetamine; Antidepressive Agents; Antitubercular Agents; Anxiety; Bipolar Disorder; Chlorpr | 1970 |
[Psychotropic activity under the influence of fenpentadiol].
Topics: Amphetamine; Animals; Anticonvulsants; Antidepressive Agents; Anxiety; Barbiturates; Cats; Central N | 1971 |
Personality attributes of the young, nonaddicted drug abuser.
Topics: Adolescent; Adult; Age Factors; Amphetamine; Antisocial Personality Disorder; Anxiety; Barbiturates; | 1972 |
Personality characteristics and drug of choice.
Topics: Amphetamine; Analysis of Variance; Anxiety; Barbiturates; Depression; Diagnosis, Differential; Femal | 1972 |
The combined abuse of alcohol and amphetamines.
Topics: Adult; Alcohol Drinking; Alcoholism; Amphetamine; Anxiety; Depression; Drug Interactions; Employment | 1974 |
Biochemical criteria for classifying depressive disorders and predicting responses to pharmacotherapy: preliminary findings from studies of norepinephrine metabolism. Contributions to biochemistry.
Topics: Adolescent; Adult; Aged; Amitriptyline; Amphetamine; Anxiety; Bipolar Disorder; Brain; Depression; F | 1974 |
Some descriptive measures on 100 consecutive VA hospital drug abuse admissions.
Topics: Adolescent; Adult; Amphetamine; Antisocial Personality Disorder; Anxiety; Barbiturates; Depression; | 1974 |
Illicit pentazocine (Talwin) use: a report of thirteen cases.
Topics: Adolescent; Adult; Amphetamine; Anxiety; Cannabis; Ethanol; Euphoria; Female; Heroin; Humans; Lyserg | 1972 |
Amphetamine and conditioned 'anxiety'.
Topics: Amphetamine; Animals; Anxiety; Conditioning, Psychological; Electroshock; Humans; Injections, Intrap | 1972 |
A drug induced koro syndrome.
Topics: Adult; Amphetamine; Anxiety; Depersonalization; Humans; Male | 1973 |
On the preferential abuse of heroin and amphetamine.
Topics: Adaptation, Psychological; Amphetamine; Anxiety; Defense Mechanisms; Ego; Heroin; Humans; Personalit | 1973 |
[Personality aspects of drug abuse by 19-year-old males (author's transl)].
Topics: Adult; Affective Symptoms; Amphetamine; Anxiety; Cannabis; Character; Depression; Hallucinogens; Hum | 1973 |
Motives for drug use among light and heavy users.
Topics: Adult; Amphetamine; Anxiety; Barbiturates; Cannabis; Cocaine; Creativity; Depression; Exploratory Be | 1974 |
Hyperactivity in children: types, diagosis, drug therapy, approaches to management.
Topics: Amphetamine; Anxiety; Attention; Attention Deficit Disorder with Hyperactivity; Brain Damage, Chroni | 1972 |
Bad drug trips and flashbacks.
Topics: Adolescent; Adult; Amphetamine; Anxiety; Depersonalization; Hallucinogens; Humans; Hysteria; Lysergi | 1972 |
Evaluation of experimental techniques in the psychopharmacology of emotion.
Topics: Amphetamine; Animals; Anxiety; Autonomic Nervous System; Avoidance Learning; Barbiturates; Behavior, | 1969 |
Amphetamine taking among young offenders.
Topics: Adolescent; Adult; Amphetamine; Anxiety; Chromatography, Thin Layer; Guilt; Humans; Introversion, Ps | 1969 |
Another abusable amphetamine.
Topics: Amphetamine; Anxiety; Fatigue; Humans; Substance-Related Disorders; Wisconsin | 1970 |
[Hallucinosis in ephedrine addiction].
Topics: Adult; Amphetamine; Anxiety; Ephedrine; Euphoria; Female; Hallucinations; Humans; Mental Disorders; | 1968 |
Effects of drugs on conditioned "anxiety".
Topics: Amphetamine; Animals; Anxiety; Behavior, Animal; Conditioning, Psychological; Electroshock; Humans; | 1968 |